The start of the COVID-19 pandemic increased anxiety and depression

Publicly released:
Australia; International; VIC
CC-0
CC-0

International scientists, including Australians, reviewed 43 previous studies, including a total of 331,628 people, conducted during the COVID-19 pandemic, finding that anxiety and depression symptoms increased in the early days of the pandemic, but after the first two months, changes in symptoms varied widely across different populations. The studies measured self-reported mental health parameters including changes in symptoms of psychological distress, sleep disturbances, and mental well-being. The authors also note that tougher lockdowns and more cases were linked with larger increases in depression and anxiety, but caution that these findings apply to the general population at the beginning of the pandemic only, and do not include important developments, such as later waves or variants of COVID-19.

Media release

From: American College of Physicians

Increased anxiety and depression symptoms appeared in early days of the pandemic
After the first 2 months, mental disorders symptoms varied significantly across populations

A review of 43 studies conducted during the COVID-19 pandemic suggests that increased number of reported infections and stringent government response to COVID-19 were associated with increased anxiety and depression symptoms in the early days of the pandemic. However, after the first 2 months, changes in symptoms varied significantly across populations. The findings are published in Annals of Internal Medicine.

Mental health experts have previously warned about the possibility of increased ill mental health due to the COVID-19 pandemic. It is important to quantify impacts on mental health to inform future public health efforts that balance minimizing both the spread of infection and possible mental health harms.

Researchers from the University of Bern, Bern, Switzerland, reviewed 43 studies comprising 331,628 participants to assess the trajectory of mental health symptoms during the first year of the pandemic and examine dose-response relations with characteristics of the pandemic and its containment. The studies measured self-reported mental health parameters including changes in symptoms of psychological distress, sleep disturbances, and mental well-being. The authors found that symptoms of depression and anxiety in the general population worsened slightly in the first 2 months of the pandemic, but mental health impacts varied significantly by population after that period. They noted that increase symptoms of depression and anxiety were associated with more stringent governmental responses and higher number of reported infections, but caution that these findings apply to the general population at the beginning of the pandemic and do not include important developments, such as later waves or variants of COVID-19. The authors suggest that while the pandemic continues and to prepare for future pandemics, governments need to ensure that adequate mental health service provision and appropriate interventions exist for those who need them.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research American College of Physicians, Web page The URL will go live after the embargo ends
Journal/
conference:
Annals of Internal Medicine
Research:Paper
Organisation/s: Orygen, The University of Melbourne
Funder: By grant 198418 from the National Research Programme 78 COVID-19 of the Swiss National Science Foundation. Dr. Cipriani is supported by the NIHR Oxford Cognitive Health Clinical Research Facility, by an NIHR Research Professorship (grant RP-2017-08-ST2-006), by the NIHR Oxford and Thames Valley Applied Research Collaboration, and by the NIHR Oxford Health Biomedical Research Centre (grant BRC-1215-20005). Dr. Haas is supported by an Ambizione fellowship from the Swiss National Science Foundation (193381). Dr. Egger was supported by special project funding (grant 189498) from the Swiss National Science Foundation. Dr. Low received funding for the COVID-19 Open Access Project from the Swiss National Science Foundation (grant 176233) and the European Union's Horizon 2020 research and innovation program, project EpiPose (grant 101003688). From the MHCOVID Crowd Investigators, Dr. Lasserre has received grant funding from the Swiss National Science Foundation Early Postdoc Mobility fellowship (P2LAP3_191273).
Media Contact/s
Contact details are only visible to registered journalists.